Consortium gathers in Birmingham for the 2025 Hypermarker annual meeting

On 7–8 May 2025, the Hypermarker consortium came together in Birmingham, United Kingdom, for its Annual Meeting, a dynamic in-person event that brought together project partners from across Europe to reflect, align, and plan forward. 

Hosted by the University of Birmingham, the two-day programme featured rich discussions across key technical, clinical, and ethical dimensions of the project, including: 

• A co-creation workshop with WP5 and strong Patient and Public Involvement and Engagement (PPIE)

• Updates on the hypertension model and clinical datasets

• Insights into health economics and ethics

• Development progress on the clinical decision support tool

• Deep dives into data harmonisation and metabolomics strategies

• Planning for communication, dissemination, and the next project phase

One of the meeting’s highlights was the active participation of patient representatives, who comprised 20% of all attendees, a powerful reflection of Hypermarker’s commitment to meaningful patient involvement throughout the research process.

With strong collaborative energy and productive exchanges, the meeting marked a key step forward in delivering on Hypermarker’s mission to advance personalised hypertension care.